Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Regulatory standards must be stronger for quality medicines: Health secy

by AIP Online Bureau | Feb 25, 2025 | Eco/Invest/Demography, Health, Indian News, Policy, Regulation, Risk Management

The meeting with state drug regulators comes in the wake of the Drugs Controller General of India (DCGI) prohibiting the production and export of all combinations of pain relief medicines tapentadol and carisoprodol, following reports that unapproved combinations of...

Recent Posts

  • (no title)
  • (no title)
  • IRDAI drops plans to change existing bancassurance rules for curbing mis-selling by insurers
  • Indian companies paid Rs4 crore on average for cyber attack demands: Report
  • SBI General announces awareness campaign for Kharif 2025

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy